| Not Yet Recruiting | Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lu Lung Non-Squamous Non-Small Cell Carcinoma | Phase 2 | 2027-06-01 |
| Not Yet Recruiting | PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients Glioblastoma | Phase 3 | 2026-12-01 |
| Not Yet Recruiting | A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Followi Skin Carcinoma | N/A | 2026-06-01 |
| Not Yet Recruiting | A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophage Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8 | — | 2026-05-01 |
| Not Yet Recruiting | Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Mi Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2026-04-30 |
| Not Yet Recruiting | Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8 | N/A | 2026-04-04 |
| Not Yet Recruiting | Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Synd Atypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm | Phase 2 | 2026-03-29 |
| Not Yet Recruiting | Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III G Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8 | N/A | 2026-03-01 |
| Not Yet Recruiting | Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer Lung Non-Small Cell Carcinoma | Phase 2 | 2026-02-01 |
| Recruiting | Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies Breast Biopsy, Anxiety, Pain | N/A | 2026-01-20 |
| Recruiting | Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Prostate Cancer | Phase 3 | 2025-12-16 |
| Recruiting | Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiother Oligometastatic Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma | Phase 2 | 2025-12-12 |
| Recruiting | Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocar Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8, Stage IA2 Lung Cancer AJCC v8 | EARLY_Phase 1 | 2025-12-02 |
| Recruiting | Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized P Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | N/A | 2025-12-01 |
| Recruiting | Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial Prostate Carcinoma | EARLY_Phase 1 | 2025-11-14 |
| Recruiting | Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients Glioblastoma | Phase 3 | 2025-10-27 |
| Recruiting | A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Ca Breast Cancer Screening, Artificial Intelligence (AI) | Phase 4 | 2025-10-15 |
| Recruiting | An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Wh Prostate Carcinoma | Phase 2 | 2025-10-09 |
| Recruiting | Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis Malignant Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain | N/A | 2025-08-28 |
| Recruiting | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog Anal Carcinoma, Bladder Carcinoma, Breast Carcinoma | Phase 1 | 2025-08-01 |
| Recruiting | External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Sta Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2025-07-29 |
| Recruiting | ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or As IDH Wildtype Glioblastoma, Recurrent Astrocytoma, IDH Wildtype Recurrent Glioblastoma | Phase 1 | 2025-07-28 |
| Recruiting | Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity Prostate Cancer (CRPC) | — | 2025-07-17 |
| Recruiting | Ivonescimab for the Treatment of Thymic Cancer Thymus Carcinoma | Phase 2 | 2025-07-15 |
| Recruiting | Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Tr Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | N/A | 2025-06-27 |
| Recruiting | Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) T-cell-prolymphocytic Leukemia, Cutaneous T-Cell Lymphoma Refractory | Phase 1 / Phase 2 | 2025-05-02 |
| Recruiting | A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal I Colorectal Carcinoma | N/A | 2025-04-22 |
| Recruiting | Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms DLL3-expressing Tumors, Advanced Tumors | Phase 2 | 2025-03-21 |
| Recruiting | Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Ca Colorectal Adenocarcinoma | Phase 1 | 2025-03-20 |
| Recruiting | Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 / Phase 2 | 2024-12-26 |
| Recruiting | Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectabl Glioma, Malignant Brain Neoplasm, Meningioma | Phase 1 | 2024-12-05 |
| Withdrawn | Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Re Diffuse Hemispheric Glioma, H3 G34-Mutant | Phase 1 | 2024-12-01 |
| Recruiting | Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatmen Head and Neck Carcinoma, Localized Head and Neck Carcinoma, Metastatic Head and Neck Carcinoma | N/A | 2024-10-25 |
| Recruiting | An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer | Phase 2 | 2024-08-06 |
| Withdrawn | Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2024-08-03 |
| Recruiting | Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPS Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | 2024-08-01 |
| Recruiting | Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castrat Prostate Carcinoma, Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Phase 2 | 2024-08-01 |
| Recruiting | Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers Endometrial Cancer, Cervical Cancer | N/A | 2024-07-24 |
| Recruiting | Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2024-07-23 |
| Recruiting | Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2 | 2024-06-26 |
| Active Not Recruiting | A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma Diffuse Hemispheric Glioma, H3 G34-Mutant | Phase 1 | 2024-06-14 |
| Recruiting | Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdom Abdominopelvic Sarcomas | Phase 2 | 2024-05-30 |
| Recruiting | Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Pr Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Phase 1 | 2024-04-26 |
| Withdrawn | CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | 2024-03-28 |
| Recruiting | Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patien Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 | Phase 2 | 2024-03-28 |
| Recruiting | An Organoid-based Functional Precision Medicine Trial in Osteosarcoma Osteosarcoma | — | 2024-02-12 |
| Active Not Recruiting | Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer Early Stage Breast Carcinoma | — | 2024-01-04 |
| Recruiting | Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps Colorectal Carcinoma | N/A | 2023-11-08 |
| Active Not Recruiting | Psychoeducation for Uveal Melanoma Uveal Melanoma | N/A | 2023-11-07 |
| Completed | Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) Ovarian Cancer | N/A | 2023-10-17 |
| Terminated | Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance Prostate Cancer | N/A | 2023-09-14 |
| Recruiting | Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Meas Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor | Phase 1 / Phase 2 | 2023-09-06 |
| Withdrawn | Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease Acute Graft Versus Host Disease, Gastrointestinal Tract Acute Graft Versus Host Disease, Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Phase 1 | 2023-09-01 |
| Terminated | Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy fo Resectable Pancreatic Carcinoma | EARLY_Phase 1 | 2023-08-10 |
| Recruiting | Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants Breast Carcinoma, Lung Carcinoma | N/A | 2023-07-28 |
| Recruiting | Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2023-03-27 |
| Recruiting | Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2023-03-07 |
| Recruiting | Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma | Phase 1 / Phase 2 | 2023-01-23 |
| Recruiting | An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Adenocarcinoma | Phase 1 / Phase 2 | 2023-01-19 |
| Active Not Recruiting | Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pa Stage III Pancreatic Cancer, Pancreatic Adenocarcinoma Non-resectable | N/A | 2023-01-17 |
| Active Not Recruiting | 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, T Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma | Phase 2 | 2022-09-02 |
| Recruiting | Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblas Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma | N/A | 2022-04-14 |
| Recruiting | Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8 | Phase 1 / Phase 2 | 2022-04-07 |
| Active Not Recruiting | Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Lo Locally Advanced Head and Neck Carcinoma | N/A | 2022-04-05 |
| Active Not Recruiting | Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Nega Prostate Carcinoma | EARLY_Phase 1 | 2022-01-13 |
| Withdrawn | Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma Mesothelioma | N/A | 2021-12-01 |
| Withdrawn | Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer Clear Cell Papillary Renal Neoplasm, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma | Phase 2 | 2021-10-18 |
| Terminated | BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | EARLY_Phase 1 | 2021-10-13 |
| Completed | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 2 | 2021-09-29 |
| Active Not Recruiting | Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma Glioma, Malignant Glioma, Recurrent Glioma | EARLY_Phase 1 | 2021-09-01 |
| Recruiting | High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC v8 | N/A | 2021-08-20 |
| Withdrawn | A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors of Childhood Cancer | EARLY_Phase 1 | 2021-07-12 |
| Recruiting | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial Neoplasia 2 | Phase 2 | 2021-06-30 |
| Recruiting | Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Ca Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIIC Prostate Cancer AJCC v8 | Phase 2 | 2021-06-23 |
| Terminated | 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Prog Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Prostate Carcinoma | Phase 2 | 2021-06-16 |
| Withdrawn | ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma | Phase 1 | 2021-05-01 |
| Recruiting | 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer Prostate Carcinoma, Recurrent Prostate Carcinoma | EARLY_Phase 1 | 2021-04-27 |
| Terminated | Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 | N/A | 2021-04-08 |
| Recruiting | Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification Prostate Carcinoma | — | 2021-04-01 |
| Active Not Recruiting | Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation, Recurrent Prostate Carcinoma | Phase 2 | 2021-03-17 |
| Recruiting | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 | Phase 1 | 2021-02-11 |
| Active Not Recruiting | Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth F Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Phase 1 / Phase 2 | 2021-01-29 |
| Terminated | Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Clinical Stage III Cutaneous Melanoma AJCC V8, Clinical Stage IV Cutaneous Melanoma AJCC V8, Locally Advanced Cutaneous Melanoma | Phase 2 | 2020-12-03 |
| Active Not Recruiting | Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Tr Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8 | N/A | 2020-11-10 |
| Active Not Recruiting | Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical P Prostate Carcinoma | N/A | 2020-10-21 |
| Recruiting | Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | 2020-10-16 |
| Active Not Recruiting | Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma | Phase 1 | 2020-10-14 |
| Recruiting | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hor Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer | Phase 2 | 2020-10-09 |
| Active Not Recruiting | Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation Metastatic Malignant Neoplasm in the Prostate Gland, Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 1 | 2020-09-09 |
| Active Not Recruiting | 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma Metastatic Sarcoma, Recurrent Sarcoma, Sarcoma | EARLY_Phase 1 | 2020-09-08 |
| Active Not Recruiting | Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers Bladder Carcinoma, Cervical Carcinoma, Cholangiocarcinoma | Phase 1 | 2020-08-27 |
| Terminated | Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 | Phase 3 | 2020-08-14 |
| Active Not Recruiting | Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractor Metastatic Malignant Female Reproductive System Neoplasm, Platinum-Resistant Malignant Female Reproductive System Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm | Phase 2 | 2020-08-07 |
| Recruiting | Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 | 2020-07-16 |
| Terminated | Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI Malignant Brain Neoplasm | N/A | 2020-07-07 |
| Recruiting | A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults Obesity, Malignant Neoplasm | N/A | 2020-07-01 |
| Terminated | Role of Children in Transmission of COVID-19 to Immunocompromised Patients Immunosuppression | — | 2020-05-27 |
| Active Not Recruiting | Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdom Rhabdomyosarcoma | Phase 1 | 2020-05-14 |
| Active Not Recruiting | CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Prostate Adenocarcinoma | — | 2020-05-12 |
| Terminated | Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Re Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Phase 1 | 2020-04-16 |
| Withdrawn | Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8 | N/A | 2020-04-03 |
| Recruiting | Brain Health in Breast Cancer Survivors Cognitive Impairment, Cognitive Function | — | 2020-03-11 |
| Terminated | Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients Wit Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma, Progressive Disease | Phase 2 | 2020-03-04 |
| Recruiting | Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyro Thyroid Gland Carcinoma, Thyroid Gland Nodule | — | 2020-02-21 |
| Active Not Recruiting | Focal Laser Ablation of Prostate Cancer Prostate Cancer | EARLY_Phase 1 | 2020-01-30 |
| Terminated | Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, KRAS Protein Variant | Phase 2 | 2020-01-14 |
| Active Not Recruiting | Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma Recurrent Glioblastoma | Phase 1 | 2020-01-08 |
| Withdrawn | Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Re Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma | Phase 2 | 2019-12-01 |
| Active Not Recruiting | Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal a Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma | EARLY_Phase 1 | 2019-11-05 |
| Active Not Recruiting | Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Gro Colorectal Carcinoma | N/A | 2019-11-01 |
| Completed | Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiv Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 | N/A | 2019-10-07 |
| Active Not Recruiting | Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphom CD19 Positive, CD20 Positive, Recurrent Chronic Lymphocytic Leukemia | Phase 1 | 2019-10-04 |
| Withdrawn | Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases Malignant Neoplasm, Brain, Brain Tumor | N/A | 2019-08-26 |
| Completed | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancrea Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | 2019-07-24 |
| Terminated | CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia Acute Myelogenous Leukemia | Phase 1 | 2019-07-18 |
| Terminated | Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Tr Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | 2019-07-10 |
| Active Not Recruiting | CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 | Phase 1 | 2019-07-08 |
| Completed | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer Prostate Carcinoma | EARLY_Phase 1 | 2019-06-05 |
| Recruiting | Pembrolizumab in Treating Participants With Leukoplakia Erythroleukoplakia, Leukoplakia, Verrucous Oral Leukoplakia | Phase 2 | 2019-05-03 |
| Completed | Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prosta Recurrent Prostate Carcinoma | Phase 2 | 2019-04-12 |
| Active Not Recruiting | CPX-351 Plus Enasidenib for Relapsed AML Recurrent Acute Myeloid Leukemia | Phase 2 | 2019-04-12 |
| Completed | SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer Positive Axillary Lymph Node, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 | EARLY_Phase 1 | 2019-04-07 |
| Completed | Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma Chordoma, Locally Advanced Chordoma, Metastatic Chordoma | Phase 2 | 2019-04-03 |
| Completed | Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer Recurrent Head and Neck Carcinoma | N/A | 2019-03-27 |
| Active Not Recruiting | Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage S Advanced Malignant Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | Phase 1 / Phase 2 | 2019-03-06 |
| Active Not Recruiting | Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma | Phase 2 | 2019-03-06 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Su PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7 | Phase 2 | 2019-01-29 |
| Active Not Recruiting | Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma | Phase 1 | 2019-01-11 |
| Completed | OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects Health Status Unknown | N/A | 2018-12-18 |
| Withdrawn | Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck C Head and Neck Carcinoma | Phase 1 / Phase 2 | 2018-12-12 |
| Active Not Recruiting | SPECT/CT for the Characterization of Renal Masses Kidney Neoplasm, Renal Mass | — | 2018-12-07 |
| Completed | 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Gliobl EGFR Gene Amplification, EGFR Gene Mutation, Glioblastoma | Phase 2 | 2018-11-28 |
| Active Not Recruiting | Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Sma Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma | Phase 2 | 2018-10-31 |
| Active Not Recruiting | Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Loca Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8, Stage IVA Bladder Cancer AJCC v8 | Phase 2 | 2018-10-26 |
| Terminated | Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Par Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 1 / Phase 2 | 2018-10-04 |
| Withdrawn | Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Primary Peritoneal High Grade Serous Adenocarcinoma | Phase 1 / Phase 2 | 2018-08-01 |
| Active Not Recruiting | Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy Recurrent Prostate Carcinoma | Phase 3 | 2018-07-12 |
| Withdrawn | TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Re HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Plasma Cell Myeloma | Phase 1 | 2018-07-10 |
| Withdrawn | Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resis Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer | N/A | 2018-06-14 |
| Terminated | Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 | Phase 1 | 2018-06-14 |
| Completed | PET Imaging of the Immune System Using Analog Probes Malignant Melanoma | — | 2018-04-10 |
| Completed | 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | 2018-04-02 |
| Withdrawn | Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachythe Stage III Prostate Adenocarcinoma | N/A | 2018-03-01 |
| Active Not Recruiting | Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | 2018-01-30 |
| Active Not Recruiting | Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Ster Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2017-10-11 |
| Enrolling By Invitation | Hemi-Gland Cryoablation for Prostate Cancer at UCLA Prostate Cancer, Prostate Adenocarcinoma, Prostate Disease | — | 2017-09-14 |
| Completed | FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma Lymphoma, Lymphoma, Non-Hodgkin, Large B Cell Diffuse Lymphoma | — | 2017-09-07 |
| Completed | Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surger Breast Neoplasm, Lesion | N/A | 2017-08-03 |
| Terminated | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma | Phase 1 | 2017-08-02 |
| Completed | MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer Benign Breast Neoplasm, Breast Carcinoma, Malignant Breast Neoplasm | EARLY_Phase 1 | 2017-07-31 |
| Terminated | Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Tre HLA-A*0201 Positive Cells Present, Locally Advanced Malignant Neoplasm, NY-ESO-1 Positive | Phase 1 | 2017-07-26 |
| Completed | Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors Cancer Survivor, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 | N/A | 2017-07-11 |
| Active Not Recruiting | Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing C Locally Advanced Head and Neck Carcinoma | Phase 2 | 2017-06-19 |
| Unknown | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breas Cancer Survivor, Early-Stage Breast Carcinoma, Stage 0 Breast Cancer | N/A | 2017-02-20 |
| Completed | Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced S Adult Solid Neoplasm, Childhood Solid Neoplasm, Metastatic Neoplasm | Phase 1 | 2017-01-03 |
| Completed | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastat Gastrointestinal Stromal Tumor | Phase 2 | 2016-12-14 |
| Completed | 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7 | N/A | 2016-12-12 |
| Completed | Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell L Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer | Phase 2 | 2016-09-15 |
| Completed | Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy Prostate Adenocarcinoma, Recurrent Prostate Carcinoma | Phase 3 | 2016-09-15 |
| Withdrawn | Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer Pancreatic Cancer | N/A | 2016-08-01 |
| Terminated | Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer Cancer of Pancreas | N/A | 2016-07-19 |
| Completed | Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage III Prostate Adenocarcinoma AJCC v7 | N/A | 2016-06-15 |
| Withdrawn | Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma Glioblastoma, Glioma | — | 2016-06-08 |
| Withdrawn | Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer | Phase 1 | 2016-06-01 |
| Active Not Recruiting | Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules Thyroid | — | 2016-05-01 |
| Recruiting | Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Co Recurrent Adult Soft Tissue Sarcoma | N/A | 2016-02-03 |
| Terminated | Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Absence of Signs or Symptoms, B-Cell Non-Hodgkin Lymphoma, Digestive System Signs and Symptoms | — | 2016-02-01 |
| Completed | Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases Autoimmune Disease, Crohn Disease, Inflammatory Disorder | EARLY_Phase 1 | 2016-01-25 |
| Withdrawn | Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemot Alopecia, Breast Cancer | N/A | 2016-01-01 |
| Completed | Focal Laser Ablation of Prostate Tissue Prostate Cancer | EARLY_Phase 1 | 2015-09-17 |
| Terminated | Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Epithelioid Mesothelioma, Pleural Malignant Mesothelioma | N/A | 2015-09-01 |
| Completed | FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma Glioblastoma | N/A | 2015-08-25 |
| Terminated | Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma Neurofibromatosis Type 2, Neuroma, Acoustic | Phase 2 | 2015-07-01 |
| Terminated | 18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions Malignant Neoplasm | — | 2015-06-12 |
| Completed | Project Connect Online: An Internet-based Intervention for Women With Breast Cancer Breast Neoplasms | N/A | 2015-06-04 |
| Completed | MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer Adult Hepatocellular Carcinoma, Metastatic Malignant Neoplasm in the Liver | EARLY_Phase 1 | 2015-06-03 |
| Withdrawn | Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Infiltrating Bladder Urothelial Carcinoma | N/A | 2015-04-22 |
| Withdrawn | Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations Recurrent Melanoma, Stage IV Melanoma | Phase 2 | 2015-01-01 |
| Completed | Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer Elevated PSA, Prostate Cancer | — | 2014-12-04 |
| Completed | Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme Glioblastoma, Recurrent Brain Neoplasm | N/A | 2014-11-12 |
| Active Not Recruiting | Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer | N/A | 2014-11-01 |
| Completed | Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metast Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications | Phase 2 | 2014-10-08 |
| Terminated | Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or Decisio Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Stage IIA Uveal Melanoma | N/A | 2014-10-01 |
| Active Not Recruiting | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostat Prostate Cancer | Phase 2 | 2014-09-23 |
| Recruiting | Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer Malignant Neoplasm | — | 2014-09-16 |
| Completed | Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer Prostate Cancer | — | 2014-09-11 |
| Terminated | Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastati Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2014-07-17 |
| Completed | PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced Metastatic Cancer, Unspecified Adult Solid Tumor | Phase 1 | 2014-06-12 |
| Completed | Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Recurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 1 | 2014-01-31 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer Adenocarcinoma of the Prostate, Stage III Prostate Cancer | N/A | 2014-01-27 |
| Completed | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Under Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer | Phase 1 | 2014-01-01 |
| Completed | Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Sta Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx | Phase 2 | 2013-12-26 |
| Completed | Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspecti Neuroendocrine Tumors | EARLY_Phase 1 | 2013-08-26 |
| Completed | Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic C Prostate Cancer, Pancreatic Cancer, Bladder Cancer | Phase 1 | 2013-08-22 |
| Active Not Recruiting | Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men Anal Carcinoma, HIV Infection, Human Papillomavirus Infection | N/A | 2013-08-01 |
| Completed | Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer Wi Central Nervous System Metastases, HER2-positive Breast Cancer, Male Breast Cancer | Phase 1 / Phase 2 | 2013-06-26 |
| Completed | Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer | Phase 1 | 2013-01-14 |
| Completed | Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Mult Newly Diagnosed Glioblastoma Multiforme | Phase 2 | 2012-12-07 |
| Active Not Recruiting | Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies Malignant Neoplasm | Phase 2 | 2012-11-02 |
| Completed | Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cel Stage IV Non-small Cell Lung Cancer | Phase 1 | 2012-09-07 |
| Completed | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma Glioma, Glioblastoma | N/A | 2012-08-22 |
| Completed | Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors Breast Cancer | N/A | 2012-08-01 |
| Completed | Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer | Phase 2 | 2012-07-16 |
| Completed | Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors Breast Cancer | Phase 2 | 2012-04-01 |
| Withdrawn | Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer | Phase 2 | 2012-03-01 |
| Completed | Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma | Phase 2 | 2012-01-10 |
| Completed | A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinas Ovarian Epithelial Carcinoma | Phase 2 | 2011-12-15 |
| Terminated | Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients W Non Small Cell Lung Cancer | N/A | 2011-11-01 |
| Completed | Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastom Brain and Central Nervous System Tumors | Phase 2 | 2011-10-03 |
| Withdrawn | Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Mela Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma | Phase 3 | 2011-08-05 |
| Completed | Predictors of Patient Attitudes and Barriers to Skin Cancer Screening Skin Cancer | — | 2011-06-01 |
| Completed | A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors Younger Breast Cancer Survivors | Phase 2 | 2011-04-01 |
| Active Not Recruiting | Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer | N/A | 2011-03-23 |
| Completed | Dendritic Cell Vaccine for Patients With Brain Tumors Glioma, Anaplastic Astrocytoma, Anaplastic Astro-oligodendroglioma | Phase 2 | 2010-10-08 |
| Withdrawn | Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2010-10-01 |
| Terminated | Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy Malignant Neoplasm | — | 2010-07-08 |
| Completed | Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention Colon Cancer, Rectal Cancer | N/A | 2010-07-01 |
| Completed | Cellular Immunotherapy Study for Brain Cancer Gliomas, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 1 | 2010-07-01 |
| Completed | Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patie Breast Cancer | — | 2010-05-01 |
| Completed | Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosa Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma | Phase 2 | 2010-04-28 |
| Completed | Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways Lung Cancer | N/A | 2010-02-08 |
| Completed | Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer Prostate Cancer | — | 2010-01-26 |
| Terminated | Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSC Metastatic Breast Cancer, Lung Cancer | Phase 2 | 2009-12-01 |
| Withdrawn | Temozolomide in Treating Patients With Invasive Pituitary Tumors Brain and Central Nervous System Tumors | Phase 2 | 2009-12-01 |
| Completed | Study of Gene Modified Immune Cells in Patients With Advanced Melanoma Metastatic Melanoma | Phase 2 | 2009-10-13 |
| Recruiting | Active Surveillance for Cancer of the Prostate (ASCaP) Prostate Cancer | — | 2009-07-04 |
| Withdrawn | Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Pancreatic Cancer | Phase 2 | 2009-05-01 |
| Completed | Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in M Anal Cancer, Nonneoplastic Condition, Precancerous Condition | N/A | 2009-03-12 |
| Completed | Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Lung Cancer | Phase 1 | 2009-02-26 |
| Completed | A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy Prostate Cancer | N/A | 2009-02-01 |
| Completed | Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 1 | 2009-01-01 |
| Completed | Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma Metastatic Melanoma | Phase 1 | 2008-12-01 |
| Terminated | Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Sarcoma | Phase 2 | 2008-08-01 |
| Completed | Breast Cancer Screening Intervention Breast Cancer | N/A | 2008-08-01 |
| Withdrawn | Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer Breast Cancer | Phase 1 | 2008-07-01 |
| Completed | The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects a Autoimmune Diseases, Cancer | — | 2008-05-01 |
| Active Not Recruiting | Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms Sleep Disorders, Sleep Initiation and Maintenance Disorders, Dyssomnias | N/A | 2008-03-01 |
| Completed | Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors Fatigue | N/A | 2008-03-01 |
| Completed | Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Particip Impoverished Population | N/A | 2008-03-01 |
| Completed | The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patient Cancer, Inflammation | — | 2007-11-01 |
| Completed | Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery Prostate Cancer | N/A | 2007-09-01 |
| Terminated | Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease) Cushing's Disease | Phase 2 | 2007-04-01 |
| Unknown | PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-A Leukemia | Phase 2 | 2007-03-01 |
| Terminated | Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes Leukemia, Myelodysplastic Syndromes | Phase 1 | 2007-02-01 |
| Completed | Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma Melanoma (Skin) | Phase 2 | 2007-01-01 |
| Terminated | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer Breast Cancer | Phase 2 | 2007-01-01 |
| Terminated | Rosiglitazone in Treating Patients With Pituitary Tumors Brain and Central Nervous System Tumors | Phase 2 | 2006-10-01 |
| Completed | Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma Brain and Central Nervous System Tumors | Phase 1 | 2006-08-01 |
| Completed | Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Brain and Central Nervous System Tumors | Phase 2 | 2006-06-01 |
| Completed | Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Pros Prostate Cancer | Phase 1 | 2006-06-01 |
| Completed | Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone Ocular Melanoma, Choroidal Melanoma, Uveal Melanoma | — | 2006-06-01 |
| Completed | Vaccine Therapy in Treating Patients With Malignant Glioma Brain and Central Nervous System Tumors | Phase 1 | 2006-05-01 |
| Completed | Bortezomib in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 2 | 2006-04-01 |
| Completed | PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Canc Sarcoma | N/A | 2006-01-01 |
| Completed | Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia Leukemia | Phase 1 | 2005-11-01 |
| Unknown | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma Lung Cancer, Lymphoma, Lymphoproliferative Disorder | Phase 1 | 2005-10-01 |
| Unknown | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 2 | 2005-09-01 |
| Completed | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors Breast Cancer, Lung Cancer, Ovarian Cancer | N/A | 2005-08-01 |
| Completed | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Anemia, Leukemia, Lymphoma | Phase 2 | 2005-08-01 |
| Unknown | Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2005-07-01 |
| Unknown | BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Leukemia | Phase 2 | 2005-03-01 |
| Terminated | Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lympho Lymphoma, Lymphoproliferative Disorder | Phase 1 | 2005-03-01 |
| Terminated | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Smal Lung Cancer | Phase 1 | 2005-02-01 |
| Terminated | Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Breast Cancer, Fatigue | Phase 2 | 2005-02-01 |
| Completed | Cytogenetic Study of Ocular Melanoma Choroidal Melanoma | — | 2005-01-08 |
| Completed | Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma Brain and Central Nervous System Tumors | Phase 1 | 2005-01-01 |
| Completed | Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma Melanoma (Skin) | Phase 2 | 2005-01-01 |
| Completed | CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fal Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2004-12-01 |
| Completed | Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2004-12-01 |
| Completed | Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy Lung Cancer | — | 2004-12-01 |
| Completed | Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer Prostate Cancer | N/A | 2004-11-30 |
| Completed | Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria Leukemia | Phase 3 | 2004-11-01 |
| Completed | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Leukemia | Phase 1 | 2004-10-01 |
| Withdrawn | Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cel Lung Cancer | Phase 1 / Phase 2 | 2004-10-01 |
| Completed | Increasing Colorectal Cancer Screening Among Filipino Americans Colorectal Cancer | N/A | 2004-09-01 |
| Completed | BMS-599626 in Treating Patients With Metastatic Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2004-08-01 |
| Unknown | Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemoth Graft Versus Host Disease, Leukemia | N/A | 2004-08-01 |
| Completed | Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2004-08-01 |
| Completed | Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Lymphoma | Phase 2 | 2004-07-01 |
| Completed | Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Pati Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | 2004-06-01 |
| Terminated | Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participan Lung Cancer | N/A | 2004-05-04 |
| Completed | Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer Breast Cancer | Phase 1 | 2004-05-01 |
| Completed | Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer Prostate Cancer | Phase 2 | 2004-05-01 |
| Completed | Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | 2004-05-01 |
| Completed | Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2004-05-01 |
| Completed | Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Und Bladder Cancer | Phase 2 | 2004-05-01 |
| Completed | CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patie Melanoma (Skin) | Phase 1 | 2004-04-01 |
| Completed | GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu Breast Cancer | Phase 1 | 2004-03-01 |
| Terminated | Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Ocular Melanoma | — | 2004-03-01 |
| Completed | ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma Melanoma (Skin) | Phase 2 | 2004-02-01 |
| Withdrawn | Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia Lymphoma | Phase 2 | 2004-01-01 |
| Withdrawn | Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer Depression, Fatigue, Ovarian Cancer | — | 2003-12-01 |
| Completed | BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Leukemia | Phase 1 | 2003-11-01 |
| Completed | Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hema Cancer | N/A | 2003-11-01 |
| Completed | Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American Women Breast Cancer | N/A | 2003-09-01 |
| Completed | Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Anemia, Leukemia, Lymphoma | Phase 3 | 2003-08-01 |
| Completed | Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 1 | 2003-08-01 |
| Completed | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cance Prostate Cancer | Phase 2 | 2003-08-01 |
| Unknown | Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatme Melanoma (Skin) | N/A | 2003-08-01 |
| Completed | Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced B Breast Cancer | Phase 2 | 2003-07-01 |
| Completed | Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Smal Anemia, Lung Cancer | Phase 2 | 2003-07-01 |
| Completed | Vaccine Therapy in Treating Patients With Malignant Glioma Brain and Central Nervous System Tumors | Phase 1 | 2003-06-01 |
| Completed | Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma Lymphoma | Phase 2 | 2003-06-01 |
| Completed | Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery Liver Cancer | Phase 2 | 2003-06-01 |
| Unknown | Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Tre Breast Cancer | Phase 1 / Phase 2 | 2003-05-01 |
| Completed | Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy Lymphoma | Phase 2 | 2003-05-01 |
| Active Not Recruiting | Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men Prostate Cancer | N/A | 2003-04-01 |
| Terminated | Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia Lymphoma | Phase 1 | 2003-04-01 |
| Completed | Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-S Lung Cancer | Phase 2 | 2003-03-01 |
| Completed | CP-724,714 in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 1 | 2003-01-01 |
| Completed | LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors Adult, Solid Tumor | Phase 1 | 2002-12-01 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer Prostate Cancer | Phase 2 | 2002-11-01 |
| Completed | Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Horm Prostate Cancer | Phase 2 | 2002-10-01 |
| Completed | Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue | N/A | 2002-09-01 |
| Completed | Sirolimus in Treating Patients With Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | 2002-07-01 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2002-07-01 |
| Completed | Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer Breast Cancer | Phase 3 | 2002-05-01 |
| Unknown | Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2002-05-01 |
| Completed | Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2002-05-01 |
| Completed | Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgk Lymphoma | Phase 1 | 2002-03-01 |
| Completed | Biological Therapy in Treating Patients With Prostate Cancer Prostate Cancer | Phase 1 | 2002-03-01 |
| Completed | Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma Melanoma (Skin) | Phase 1 / Phase 2 | 2002-03-01 |
| Completed | Low-Fat Fish Oil Diet for Prostate Cancer Prevention Prostate Cancer | N/A | 2001-12-18 |
| Unknown | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Fever, Sweats, and Hot Flashes, Infection, Leukemia | Phase 3 | 2001-09-01 |
| Unknown | Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma Lymphoma | Phase 3 | 2001-09-01 |
| Unknown | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2001-09-01 |
| Unknown | Gemtuzumab in Treating Patients With Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 2 | 2001-09-01 |
| Completed | Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia Lymphoma | Phase 2 | 2001-09-01 |
| Completed | Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated Wit Breast Cancer | Phase 1 / Phase 2 | 2001-08-01 |
| Completed | Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer Prostate Cancer | Phase 2 | 2001-08-01 |
| Completed | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer, Gastric Cancer | Phase 3 | 2001-07-01 |
| Completed | Cryosurgery in Treating Women With Breast Lesions Breast Cancer | Phase 1 | 2001-05-01 |
| Unknown | Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ov Ovarian Cancer | Phase 2 | 2001-05-01 |
| Completed | STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocyt Leukemia | Phase 1 / Phase 2 | 2001-05-01 |
| Unknown | Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 | 2001-04-01 |
| Completed | Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers Lung Cancer | Phase 2 | 2001-03-01 |
| Unknown | Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia Leukemia | Phase 2 | 2001-02-01 |
| Completed | Vaccine Therapy in Treating Patients With Liver Cancer Liver Cancer | Phase 1 / Phase 2 | 2001-01-01 |
| Unknown | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 2000-12-01 |
| Unknown | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Prostate Cancer | Phase 1 | 2000-12-01 |
| Completed | Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain Metastatic Cancer | Phase 2 | 2000-10-01 |
| Completed | Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer Kidney Cancer | Phase 1 / Phase 2 | 2000-09-01 |
| Completed | CCI-779 in Treating Patients With Prostate Cancer Prostate Cancer | Phase 2 | 2000-09-01 |
| Completed | Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer Lung Cancer, Malignant Mesothelioma, Metastatic Cancer | Phase 2 | 2000-05-01 |
| Completed | Vaccine Therapy in Treating Patients With Advanced Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-04-01 |
| Completed | Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | 2000-04-01 |
| Completed | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lun Colorectal Cancer, Esophageal Cancer, Kidney Cancer | Phase 1 | 2000-04-01 |
| Completed | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach Esophageal Cancer, Gastric Cancer | Phase 2 | 2000-04-01 |
| Completed | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer Drug/Agent Toxicity by Tissue/Organ, Leukemia, Lymphoma | Phase 2 | 2000-01-01 |
| Completed | Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia Lymphoma | Phase 2 | 1999-12-01 |
| Completed | Comparison of Screening Tests in Detecting Cervical Neoplasia Cervical Cancer | N/A | 1999-12-01 |
| Completed | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Ha Head and Neck Cancer | Phase 2 | 1999-11-01 |
| Completed | Vaccine Therapy in Treating Patients With Liver Cancer Liver Cancer | Phase 1 / Phase 2 | 1999-07-01 |
| Completed | Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Lymphoma | Phase 2 | 1999-05-01 |
| Unknown | Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma Brain and Central Nervous System Tumors | Phase 2 | 1999-02-01 |
| Completed | Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Bre Breast Cancer | Phase 3 | 1999-01-01 |
| Unknown | Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | 1998-12-01 |
| Completed | Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma Brain and Central Nervous System Tumors | N/A | 1998-11-01 |
| Withdrawn | SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients Wit Liver Cancer | Phase 2 | 1998-10-01 |
| Completed | Irinotecan in Treating Patients With Esophageal or Stomach Cancer Esophageal Cancer, Gastric Cancer | Phase 2 | 1998-08-01 |
| Completed | Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas Brain and Central Nervous System Tumors | Phase 1 | 1998-07-01 |
| Completed | Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 1 | 1998-07-01 |
| Withdrawn | Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Pati Brain and Central Nervous System Tumors | Phase 2 | 1998-03-01 |
| Completed | Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases Metastatic Cancer | N/A | 1997-12-01 |
| Completed | Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodg Lymphoma | Phase 2 | 1997-11-01 |
| Completed | Diet and Estrogen Metabolism in Postmenopausal Women Breast Cancer | N/A | 1997-08-01 |
| Completed | Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma Melanoma | Phase 1 | 1997-07-01 |
| Completed | Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 / Phase 2 | 1997-07-01 |
| Completed | Vaccine Therapy in Treating Patients With Advanced Kidney Cancer Kidney Cancer | Phase 1 | 1997-06-01 |
| Completed | Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer Head and Neck Cancer | Phase 2 | 1997-06-01 |
| Completed | Radiation Therapy Following Surgery to Remove Brain Metastases Metastatic Cancer | N/A | 1997-03-01 |
| Unknown | SU006668 in Treating Patients With Advanced Solid Tumors Breast Cancer, Colorectal Cancer, Gastric Cancer | Phase 1 | — |
| No Longer Available | Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trame Progressive Metastatic Castrate Resistant Prostate Cancer | — | — |
| No Longer Available | C11 Sodium Acetate PET/CT Imaging of PCa Prostate Cancer | — | — |
| Completed | Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Canc Anemia, Breast Cancer, Fatigue | Phase 4 | — |
| Withdrawn | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer Leukemia, Lymphoma, Myelodysplastic Syndromes | Phase 1 | — |
| Unknown | Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease Graft Versus Host Disease | Phase 1 / Phase 2 | — |
| Withdrawn | BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer | Phase 2 | — |
| Unknown | Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | — |
| Withdrawn | Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia Graft Versus Host Disease, Leukemia | Phase 2 | — |
| Unknown | Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | — |
| Withdrawn | Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer Liver Cancer | Phase 1 / Phase 2 | — |
| Approved For Marketing | Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging Prostate Cancer | — | — |
| Withdrawn | Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Unresectable Extrahepatic Bile Duct Cancer | Phase 3 | — |
| Completed | Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | — |
| No Longer Available | 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access) Carcinoid Cancer, Neuroendocrine Tumors, Medullary Thyroid Cancer | — | — |
| Unknown | SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | — |
| No Longer Available | Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma Urothelial Carcinoma Ureteral Location | — | — |
| No Longer Available | Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma Ewing Sarcoma | — | — |
| Unknown | ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer Lung Cancer | Phase 2 | — |
| Unknown | INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer Lung Cancer | N/A | — |